Skip to main content
PMC home page
Brain Pathology logoLink to Brain Pathology
. 2006 Apr 5;13(4):539–553. doi: 10.1111/j.1750-3639.2003.tb00484.x

TRAIL Triggers Apoptosis in Human Malignant Glioma Cells Through Extrinsic and Intrinsic Pathways

Jin H Song 1, Doyoun K Song 1, Beata Pyrzynska 2, Kenneth C Petruk 3, Erwin G Van Meir 2, Chunhai Hao 1,✉
PMCID: PMC8096004  PMID: 14655759

Abstract

Many malignant glioma cells express death receptors for tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL), yet some of these cells are resistant to TRAIL. Here, we examined signaling events in TRAIL‐induced apoptosis and searched for therapeutic agents that could overcome TRAIL resistance in glioma cells. TRAIL induced apoptosis through death receptor 5 (DR5) and was mediated by caspase‐8‐initiated extrinsic and intrinsic mitochondrial pathways in sensitive glioma cell lines. TRAIL also triggered apoptosis in resistant glioma cell lines through the same pathways, but only if the cells were pretreated with chemotherapeutic agents, cisplatin, camptothecin and etoposide. Previous studies suggested that this was due to an increase in DR5 expression in wild‐type TP53 cells, but this mechanism did not account for cells with mutant TP53. Here, we show that a more general effect of these agents is to down regulate caspase‐8 inhibitor c‐FLIPS (the short form of cellular Fasassociated death domain‐like interleukin‐1‐converting enzyme‐inhibitory protein) and up‐regulate Bak, a pro‐apoptotic Bcl‐2 family member, independently of cell's TP53 status. Furthermore, we showed that TRAIL alone or in combination with chemotherapeutic agents, induced apoptosis in primary tumor cultures from patients with malignant gliomas, reinforcing the potential of TRAIL as an effective therapeutic agent for malignant gliomas.

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

References

  • 1. Arizono Y, Yoshikawa H, Naganuma H, Hamada Y, Nakajima Y, Tasaka K (2003) A mechanism of resistance to TRAIL/Apo2L‐induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents. Br J Cancer 88:298–306. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Ashkenazi A, Dixit VM (1998) Death receptors: signaling and modulation. Science 281:1305–1308. [DOI] [PubMed] [Google Scholar]
  • 3. Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH (1999) Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155–162. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Bodmer JL, Holler N, Reynard S, Vinciguerra P, Schneider P, Juo P, Blenis J, Tschopp J (2000) TRAIL receptor‐2 signals apoptosis through FADD and caspase‐8. Nat Cell Biol 2:241–243. [DOI] [PubMed] [Google Scholar]
  • 5. Boldin MP, Goncharov TM, Goltsev YV, Wallach D (1996) Involvement of MACH, a novel MORT1/FADD‐interacting protease, in Fas/APO‐1 ‐and TNF receptor‐induced cell death. Cell 85:803–815. [DOI] [PubMed] [Google Scholar]
  • 6. Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L (1997) Death receptor 5, a new member of the TNFR family, and DR4 induce FADD‐dependent apoptosis and activate the NF‐kappaB pathway. Immunity 7:821–830. [DOI] [PubMed] [Google Scholar]
  • 7. Deng Y, Lin Y, Wu X (2002) TRAIL‐induced apoptosis requires Bax‐dependent mitochondrial release of Smac/DIABLO. Genes Dev 16:33–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Desagher S, Martinou JC (2000) Mitochondria as the central control point of apoptosis. Trends Cell Biol 10:369–377. [DOI] [PubMed] [Google Scholar]
  • 9. Du C, Fang M, Li Y, Li L, Wang X (2000) Smac, a mitochondrial protein that promotes cytochrome c‐dependent caspase activation by eliminating IAP inhibition. Cell 102:33–42. [DOI] [PubMed] [Google Scholar]
  • 10. Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, Yu JS (2002) Induction of glioblastoma apoptosis using neural stem cell‐mediated delivery of tumor necrosis factor‐related apoptosis‐inducing ligand. Cancer Res 62:7170–7174. [PubMed] [Google Scholar]
  • 11. Evdokiou A, Bouralexis S, Atkins GJ, Chai F, Hay S, Clayer M, Findlay DM (2002) Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to Apo2L/TRAIL‐induced apoptosis. Int J Cancer 99:491–504. [DOI] [PubMed] [Google Scholar]
  • 12. Ferreira CG, Span SW, Peters GJ, Kruyt FA, Giaccone G (2000) Chemotherapy triggers apoptosis in a caspase‐8‐dependent and mitochondria‐controlled manner in the non‐small cell lung cancer cell line NCI‐H460. Cancer Res 60:7133–7141. [PubMed] [Google Scholar]
  • 13. Fulda S, Wick W, Weller M, Debatin KM (2002) Smac agonists sensitize for Apo2L/TRAIL‐ or anticancer druginduced apoptosis and induce regression of malignant glioma in vivo. Nat Med 8:808–815. [DOI] [PubMed] [Google Scholar]
  • 14. Gibson SB, Oyer R, Spalding AC, Anderson SM, Johnson GL (2000) Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL. Mol Cell Biol 20:205–212. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Green DR, Reed JC (1998) Mitochondria and apoptosis. Science 281:1309–1312. [DOI] [PubMed] [Google Scholar]
  • 16. Gross A, Jockel J, Wei MC, Korsmeyer SJ (1998) Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. Embo J 17:3878–3885. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Gross A, Yin XM, Wang K, Wei MC, Jockel J, Milliman C, Erdjument‐Bromage H, Tempst P, Korsmeyer SJ (1999) Caspase cleaved BID targets mitochondria and is required for cytochrome c release, while BCL‐XL prevents this release but not tumor necrosis factor‐R1/Fas death. J Biol Chem 274:1156–1163. [DOI] [PubMed] [Google Scholar]
  • 18. Gu J, Dong RP, Zhang C, McLaughlin DF, Wu MX, Schlossman SF (1999) Functional interaction of DFF35 and DFF45 with caspase‐activated DN A fragmentation nuclease DFF40. J Biol Chem 274:20759–20762. [DOI] [PubMed] [Google Scholar]
  • 19. Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir EG, Yong VW, Parney IF, Roa WH, Petruk KC (2001) Induction and intracellular regulation of tumor necrosis factor‐related apoptosis‐inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells. Cancer Res 61:1162–1170. [PubMed] [Google Scholar]
  • 20. Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, Bayer E, Walczak H, Kalthoff H, Ungefroren H (2000) Bcl‐XL protects pancreatic adenocarcinoma cells against CD95‐ and TRAIL‐receptor‐mediated apoptosis. Oncogene 19:5477–5486. [DOI] [PubMed] [Google Scholar]
  • 21. Ikeda J, Tada M, Ishii N, Saya H, Tsuchiya K, Okaichi K, Mishima K, Sawamura Y, Fulci G, Liu TJ, Van Meir EG (2001) Restoration of endogenous wild‐type p53 activity in a glioblastoma cell line with intrinsic temperature‐sensitive p53 induces growth arrest but not apoptosis. Int J Cancer 94:35–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Irmler M, Thome M, Hahne M, Schneider P, Hofmann K, Steiner V, Bodmer JL, Schroter M, Burns K, Mattmann C, Rimoldi D, French LE, Tschopp J (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190–195. [DOI] [PubMed] [Google Scholar]
  • 23. Ishii N, Maier D, Merlo A, Tada M, Sawamura Y, Diserens AC, Van Meir EG (1999) Frequent co‐alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol 9:469–479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH, Peter ME (1995) Cytotoxicity‐dependent APO‐1 (Fas/CD95)‐associated proteins form a death‐inducing signaling complex (DISC) with the receptor. Embo J 14:5579–5588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Kischkel FC, Lawrence DA, Chuntharapai A, Schow P, Kim KJ, Ashkenazi A (2000) Apo2L/TRAIL‐dependent recruitment of endogenous FADD and caspase‐8 to death receptors 4 and 5. Immunity 12:611–620. [DOI] [PubMed] [Google Scholar]
  • 26. Kuang AA, Diehl GE, Zhang J, Winoto A (2000) FADD is required for DR4‐ and DR5‐mediated apoptosis: lack of trail‐induced apoptosis in FADD‐deficient mouse embryonic fibroblasts. J Biol Chem 275:25065–25068. [DOI] [PubMed] [Google Scholar]
  • 27. Lacour S, Hammann A, Wotawa A, Corcos L, Solary E, Dimanche‐Boitrel MT (2001) Anticancer agents sensitize tumor cells to tumor necrosis factor‐related apoptosis‐inducing ligand‐mediated caspase‐8 activation and apoptosis. Cancer Res 61:1645–1651. [PubMed] [Google Scholar]
  • 28. Lawrence D, Shahrokh Z, Marsters S, Achilles K, Shih D, Mounho B, Hillan K, Totpal K, DeForge L, Schow P, Hooley J, Sherwood S, Pai R, Leung S, Khan L, Gliniak B, Bussiere J, Smith CA, Strom SS, Kelley S, Fox JA, Thomas D, Ashkenazi A (2001) Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med 7:383–385. [DOI] [PubMed] [Google Scholar]
  • 29. LeBlanc H, Lawrence D, Varfolomeev E, Totpal K, Morlan J, Schow P, Fong S, Schwall R, Sinicropi D, Ashkenazi A (2002) Tumor‐cell resistance to death receptor—induced apoptosis through mutational inactivation of the proapop‐totic Bcl‐2 homolog Bax. Nat Med 8:274–281. [DOI] [PubMed] [Google Scholar]
  • 30. Lee J, Hampl M, Albert P, Fine HA (2002) Antitumor activity and prolonged expression from a TRAIL‐expressing adenoviral vector. Neoplasia 4:312–323. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X (1997) Cytochrome c and dATP‐dependent formation of Apaf‐1/caspase‐9 complex initiates an apoptotic protease cascade. Cell 91:479–489. [DOI] [PubMed] [Google Scholar]
  • 32. Liu X, Kim CN, Yang J, Jemmerson R, Wang X (1996) Induction of apoptotic program in cell‐free extracts: requirement for dATP and cytochrome c. Cell 86:147–157. [DOI] [PubMed] [Google Scholar]
  • 33. Liu X, Zou H, Slaughter C, Wang X (1997) DFF, a heterodimeric protein that functions downstream of cas‐pase‐3 to trigger DNA fragmentation during apoptosis. Cell 89:175–184. [DOI] [PubMed] [Google Scholar]
  • 34. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94:481–490. [DOI] [PubMed] [Google Scholar]
  • 35. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH, Peter ME (1997) FLICE is activated by association with the CD95 death‐inducing signaling complex (DISC). Embo J 16:2794–2804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36. Meng RD, El‐Deiry WS (2001) p53‐independent upregulation of KILLER/DR5 TRAIL receptor expression by glucocorticoids and interferon‐gamma. Exp Cell Res 262:154–169. [DOI] [PubMed] [Google Scholar]
  • 37. Munshi A, Pappas G, Honda T, McDonnell TJ, Younes A, Li Y, Meyn RE (2001) TRAIL (APO‐2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl‐2. Oncogene 20:3757–3765. [DOI] [PubMed] [Google Scholar]
  • 38. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM (1996) FLICE, a novel FADD‐homologous ICE/CED‐3‐like protease, is recruited to the CD95 (Fas/APO‐1) death—inducing signaling complex. Cell 85:817–827. [DOI] [PubMed] [Google Scholar]
  • 39. Muzio M, Stockwell BR, Stennicke HR, Salvesen GS, Dixit VM (1998) An induced proximity model for caspase‐8 activation. J Biol Chem 273:2926–2930. [DOI] [PubMed] [Google Scholar]
  • 40. Nagane M, Pan G, Weddle JJ, Dixit VM, Cavenee WK, Huang HJ (2000) Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor‐related apoptosis‐inducing ligand in vitro and in vivo. Cancer Res 60:847–853. [PubMed] [Google Scholar]
  • 41. Nimmanapalli R, Perkins CL, Orlando M, O'Bryan E, Nguyen D, Bhalla KN (2001) Pretreatment with paclitaxel enhances apo‐2 ligand/tumor necrosis factor‐related apoptosis‐inducing ligand‐induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels. Cancer Res 61:759–763. [PubMed] [Google Scholar]
  • 42. Ogasawara J, Watanabe‐Fukunaga R, Adachi M, Mat‐suzawa A, Kasugai T, Kitamura Y, Itoh N, Suda T, Nagata S (1993) Lethal effect of the anti‐Fas antibody in mice. Nature 364:806–809. [DOI] [PubMed] [Google Scholar]
  • 43. Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM (1997) An antagonist decoy receptor and a death domain‐containing receptor for TRAIL. Science 277:815–818. [DOI] [PubMed] [Google Scholar]
  • 44. Pan G, O'Rourke K, Chinnaiyan AM, Gentz R, Ebner R, Ni J, Dixit VM (1997) The receptor for the cytotoxic ligand TRAIL. Science 276:111–113. [DOI] [PubMed] [Google Scholar]
  • 45. Parney IF, Petruk KC, Zhang C, Farr‐Jones M, Sykes DB, Chang LJ (1997) Granulocyte‐macrophage colony‐stimulating factor and B7‐2 combination immunogene therapy in an allogeneic Hu‐PBL‐SCID/beige mouse‐human glioblastoma multiforme model. Hum Gene Ther 8:1073–1085. [DOI] [PubMed] [Google Scholar]
  • 46. Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996) Induction of apoptosis by Apo‐2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687–12690. [DOI] [PubMed] [Google Scholar]
  • 47. Rokhlin OW, Guseva N, Tagiyev A, Knudson CM, Cohen MB (2001) Bcl‐2 oncoprotein protects the human prostatic carcinoma cell line PC3 from TRAIL‐mediated apoptosis. Oncogene 20:2836–2843. [DOI] [PubMed] [Google Scholar]
  • 48. Roth W, Isenmann S, Naumann U, Kugler S, Bahr M, Dichgans J, Ashkenazi A, Weller M (1999) Locoregional Apo2L/TRAIL eradicates intracranial human malignant glioma xenografts in athymic mice in the absence of neurotoxicity. Biochem Biophys Res Commun 265:479–483. [DOI] [PubMed] [Google Scholar]
  • 49. Samali A, Cai J, Zhivotovsky B, Jones DP, Orrenius S (1999) Presence of a pre‐apoptotic complex of pro‐cas‐pase‐3, Hsp60 and Hsp 10 in the mitochondrial fraction of jurkat cells. Embo J 18:2040–2048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50. Scaffidi C, Schmitz I, Krammer PH, Peter ME (1999) The role of c‐FLIP in modulation of CD95‐induced apoptosis. J Biol Chem 274:1541–1548. [DOI] [PubMed] [Google Scholar]
  • 51. Schilling PJ, Murray JL, Markowitz AB (1992) Novel tumor necrosis factor toxic effects. Pulmonary hemorrhage and severe hepatic dysfunction. Cancer 69:256–260. [DOI] [PubMed] [Google Scholar]
  • 52. Schneider P, Bodmer JL, Thome M, Hofmann K, Holler N, Tschopp J (1997) Characterization of two receptors for TRAIL. FEBS Lett 416:329–334. [DOI] [PubMed] [Google Scholar]
  • 53. Screaton GR, Mongkolsapaya J, Xu XN, Cowper AE, McMichael AJ, Bell JI (1997) TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr Biol 7:693–696. [DOI] [PubMed] [Google Scholar]
  • 54. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace AJ, Jr. , El‐Deiry WS (1998) p53‐dependent and ‐independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 58:1593–1598. [PubMed] [Google Scholar]
  • 55. Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A (1997) Control of TRAI L‐induced apoptosis by a family of signaling and decoy receptors. Science 277:818–821. [DOI] [PubMed] [Google Scholar]
  • 56. Shu HB, Halpin DR, Goeddel DV (1997) Casper is a FADD‐ and caspase‐related inducer of apoptosis. Immunity 6:751–763. [DOI] [PubMed] [Google Scholar]
  • 57. Song JH, Song DK, Herlyn M, Petruk KC, Hao C (2003) Cisplatin down‐regulation of cellular Fas‐associated death domain‐like interleukin‐1β‐converting enzyme‐like inhibitory proteins to restore tumor necrosis factor‐related apoptosis‐inducing ligand‐induced apoptosis in human melanoma cells. Clin Cancer Res 9:4255–4266. [PubMed] [Google Scholar]
  • 58. Srinivasula SM, Ahmad M, Fernandes‐Alnemri T, Alnemri ES (1998) Autoactivation of procaspase‐9 by Apaf‐1‐mediated oligomerization. Mol Cell 1:949–957. [DOI] [PubMed] [Google Scholar]
  • 59. Srinivasula SM, Hegde R, Saleh A, Datta P, Shiozaki E, Chai J, Lee RA, Robbins PD, Fernandes‐Alnemri T, Shi Y, Alnemri ES (2001) A conserved XIAP‐interaction motif in caspase‐9 and Smac/DIABLO regulates caspase activity and apoptosis. Nature 410:112–116. [DOI] [PubMed] [Google Scholar]
  • 60. Sun SY, Yue P, Zhou JY, Wang Y, Choi Kim HR, Lotan R, Wu GS (2001) Overexpression of BCL2 blocks TNF‐related apoptosis‐inducing ligand (TRAIL)‐induced apoptosis in human lung cancer cells. Biochem Biophys Res Commun 280:788–797. [DOI] [PubMed] [Google Scholar]
  • 61. Susin SA, Lorenzo HK, Zamzami N, Marzo I, Snow BE, Brothers GM, Mangion J, Jacotot E, Costantini P, Loeffler M, Larochette N, Goodlett DR, Aebersold R, Siderovski DP, Penninger JM, Kroemer G (1999) Molecular characterization of mitochondrial apoptosis‐inducing factor. Nature 397:441–446. [DOI] [PubMed] [Google Scholar]
  • 62. Takeda K, Hayakawa Y, Smyth MJ, Kayagaki N, Yamaguchi N, Kakuta S, Iwakura Y, Yagita H, Okumura K (2001) Involvement of tumor necrosis factor‐related apoptosis‐inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat Med 7:94–100. [DOI] [PubMed] [Google Scholar]
  • 63. Verhagen AM, Ekert PG, Pakusch M, Silke J, Connolly LM, Reid GE, Moritz RL, Simpson RJ, Vaux DL (2000) Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102:43–53. [DOI] [PubMed] [Google Scholar]
  • 64. Wagenknecht B, Glaser T, Naumann U, Kugler S, Isenmann S, Bahr M, Korneluk R, Liston P, Weller M (1999) Expression and biological activity of X‐linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ 6:370–376. [DOI] [PubMed] [Google Scholar]
  • 65. Walczak H, Degli‐Esposti MA, Johnson RS, Smolak PJ, Waugh JY, Boiani N, Timour MS, Gerhart MJ, Schooley KA, Smith CA, Goodwin RG, Rauch CT (1997) TRAIL‐R2: a novel apoptosis‐mediating receptor for TRAIL. Embo J 16:5386–5397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH (1999) Tumoricidal activity of tumor necrosis factor‐related apoptosis‐inducing ligand in vivo. Nat Med 5:157–163. [DOI] [PubMed] [Google Scholar]
  • 67. Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, Korsmeyer SJ (2000) tBID, a membrane‐targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev 14:2060–2071. [PMC free article] [PubMed] [Google Scholar]
  • 68. Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, et al. (1995) Identification and characterization of a new member of the TN F family that induces apoptosis. Immunity 3:673–682. [DOI] [PubMed] [Google Scholar]
  • 69. Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ (1997) Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol 139:1281–1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Wu GS, Burns TF, McDonald ER, 3rd , Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou JY, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G, El‐Deiry WS (1997) KILLER/DR5 is a DNA damage‐inducible p53‐regulated death receptor gene. Nat Genet 17:141–143. [DOI] [PubMed] [Google Scholar]
  • 71. Xiao C, Yang BF, Asadi N, Beguinot F, Hao C (2002) Tumor necrosis factor‐related apoptosis‐inducing ligand‐induced death‐inducing signaling complex and its modulation by c‐FLIP and PED/PEA‐15 in glioma cells. J Biol Chem 277:25020–25025. [DOI] [PubMed] [Google Scholar]
  • 72. Yang BF, Xiao C, Roa WH, Krammer PH, Hao C (2003) Calcium/calmodulin‐dependent protein kinase II regulation of c‐FLIP expression and phosphorylation in modulation of Fas‐mediated signaling in malignant glioma cells. J Biol Chem 278:7043–7050. [DOI] [PubMed] [Google Scholar]
  • 73. Zhang XD, Franco A, Myers K, Gray C, Nguyen T, Hersey P (1999) Relation of TNF‐related apoptosis‐inducing ligand (TRAIL) receptor and FLICE‐inhibitory protein expression to TRAIL‐induced apoptosis of melanoma. Cancer Res 59:2747–2753. [PubMed] [Google Scholar]
  • 74. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X (1997) Apaf‐1, a human protein homologous to C. elegans CED‐4, participates in cytochrome c‐dependent activation of caspase‐3. Cell 90:405–413. [DOI] [PubMed] [Google Scholar]

Articles from Brain Pathology are provided here courtesy of Wiley

RESOURCES